2017 International Congress Archives - Page 3 of 155

A double-blind, randomized, placebo controlled study of botulinum toxin type A for limb pain in advanced Parkinson’s disease

V. Bruno, M. Freitas, D. Mancini, J. Liu, J. Miyasaki, S. Fox (CABA, Argentina)
A follow-up study of hyperechogenicity of the substantia nigra in Parkinson’s disease and atypical parkinsonian syndrome

J. Horie, H. Fujita, K. Suzuki, A. Numao, Y. Watanabe, T. Matsubara, T. Uchiyama, T. Miyamoto, M. Miyamoto, T. Kadowaki, K. Hirata (Shimotsuga-gun, Japan)
A global survey of the use and linguistic translation of the NMSQuest and NMSScale: implications for non-motor studies in Parkinson’s disease

A. Sauerbier, L. Klingelhoefer, R. Banerjee, S. Diaconu, R. Erro, T. Farombi, S. Gangadharan, A. Macerollo, L. Chahine, O. Jitkritsadakul, R. Biundo, M. Grilo, H. Dafsari, G. Pagano, F. Niccolini, N. Titova (London, United Kingdom)
A kinematic analysis of finger tapping in dystonia

R. Newby, S. Muhamed, S. Smith, J. Alty, S. Jamieson, P. Kempster (Melbourne, Australia)
A long-term study on effectiveness of levodopa-carbidopa intestinal gel treatment in advanced Parkinson’s disease patients

K.R. Chaudhuri, A. Antonini, W. Poewe, D. Standaert, P. Odin, J. Zamudio, L. Bergmann (London, United Kingdom)
A member of the HSP40/DNAJ family is a novel gene for early-onset parkinsonism

L. Straniero, I. Guella, V. Rimoldi, L. Parkkinen, A. Young, R. Asselta, J. Follett, G. Soldà, E. Saba, V. Sossi, J. Stoessl, K. Nishioka, N. Hattori, A. Rajput, R. Cilia, S. Goldwurm, M. Farrer, G. Pezzoli, A. Rajput, S. Duga (Rozzano-Milano, Italy)
A model community neurofitness and wellness center for people with Parkinson disease. 1-year group pilot data

E. Borchers, B. Farley, D. Snider, T. McIsaac, J. Bazan-Wigle (Tucson, AZ, USA)
A modified model for prediction of Huntington disease age of onset based on length of CAG repeat expansion

Y. Seliverstov, E. Shulgina, S. Illarioshkin, M. Belyaev (Moscow, Russian Federation)
A national Swedish self-management program for people with Parkinson’s disease – patients and relatives view

C. Hellqvist, C. Berterö, M. Levander, N. Dizdar, P. Hagell (Linköping, Sweden)
A neuroimaging-based model for disease progression in Parkinson’s disease

N. Shenkov, I. Klyuzhin, A. Rahmim, V. Sossi (Vancouver, BC, Canada)